Myasthenia Gravis Treatments

Find Myasthenia Gravis Treatments

Generic Name

Pyridostigmine

Brand Names
Pryidostigmine, Mestinon, Regonol
FDA approval date: April 06, 1955
Classification: Cholinesterase Inhibitor
Form: Injection, Tablet, Solution

What is Pryidostigmine (Pyridostigmine)?

INDICATION: Pyridostigmine Bromide Oral Solution, USP is useful in the treatment of myasthenia gravis.

Approved To Treat

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Double-Blind, Placebo-Controlled Study of Pyridostigmine in Postural Tachycardia Syndrome

Summary: This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.

The Effect of Administration of Sugammadex on the Occurrence of Emergence Agitation in Pediatric Strabismus Surgery-prospective Randomized Controlled Trial

Summary: The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine

Pyridostigmine for the Treatment of Constipation in Parkinson Disease

Summary: Constipation is a common and debilitating non-motor symptom of Parkinson disease (PD) that often precedes the onset of classic motor symptoms by decades. There is no standardized algorithm for managing constipation in this patient population, nor are there dedicated treatments. Studies suggest that constipation can affect quality of life to a significant degree, in many cases just as much as motor...

Brand Information